By HAK News 

Moderna MRNA Stock Forecast 2022 - 2023 2025 - 2030

Moderna, Inc.  Based on messenger ribonucleic acid, company is manufactures of transformational medications (mRNA).

Moderna Inc., MRNA

Moderna MRNA The Company has grown Revenue @ 468.99% CAGR annually in its last 3 years

Moderna Inc., MRNA

Moderna MRNA The Company has grown Net Income @ 226.45% CAGR annually in its last 3 year

Moderna Inc., MRNA

Moderna MRNA The Company Stock Price has grown @ 126.79% CAGR annually in its last 3 years

Moderna Inc., MRNA

Moderna MRNA Stock Forecast

Moderna MRNA Stock Forecast 2022

Moderna Inc., MRNA

Moderna MRNA Stock is expected to reach a maximum level of $228 at the end of 2022

Moderna MRNA Stock Forecast 2023

Moderna Inc., MRNA

Moderna MRNA Stock is expected to reach a maximum level of $288 at the end of 2023

Moderna MRNA Stock Forecast 2025

Moderna Inc., MRNA

Moderna MRNA Stock is expected to reach a maximum level of $445 at the end of 2025

Moderna MRNA Stock Forecast 2030

Moderna Inc., MRNA

Moderna MRNA Stock is expected to reach a maximum level of $1415 at the end of 2030

FOR LATEST STOCKS FORECAST VISIT OUR WEBSITE

Thanks for Watching our Web Story